|
BET1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.274099714621E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.31720001572688E-09 |
| Normal-vs-Stage2 |
2.47539999999047E-05 |
| Normal-vs-Stage3 |
8.2391999889353E-09 |
| Normal-vs-Stage4 |
1.15109999310192E-09 |
| Stage1-vs-Stage2 |
8.830400E-01 |
| Stage1-vs-Stage3 |
2.418200E-01 |
| Stage1-vs-Stage4 |
7.663900E-03 |
| Stage2-vs-Stage3 |
5.554800E-01 |
| Stage2-vs-Stage4 |
9.109900E-02 |
| Stage3-vs-Stage4 |
1.402760E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51429979666773E-11 |
| Normal-vs-AfricanAmerican |
3.75650000000727E-05 |
| Normal-vs-Asian |
9.26909999865444E-08 |
| Caucasian-vs-AfricanAmerican |
8.989600E-01 |
| Caucasian-vs-Asian |
9.066000E-01 |
| AfricanAmerican-vs-Asian |
9.710800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.05170358269902E-11 |
| Normal-vs-Female |
2.80970002819458E-09 |
| Male-vs-Female |
1.545750E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.85130002836343E-09 |
| Normal-vs-Age(41-60Yrs) |
3.56009999258333E-09 |
| Normal-vs-Age(61-80Yrs) |
3.70810049332704E-10 |
| Normal-vs-Age(81-100Yrs) |
5.058600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.564200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.239800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.219900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.826440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.188200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.409720E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.705600E-01 |
| Classical-VS-Follicular |
3.649200E-01 |
| Classical-VS-Other |
5.118400E-01 |
| Classical-VS-Normal |
1.47939993588864E-10 |
| Tall-VS-Follicular |
1.080410E-01 |
| Tall-VS-Other |
9.289000E-01 |
| Tall-VS-Normal |
2.63590000049163E-07 |
| Follicular-VS-Other |
4.388800E-01 |
| Follicular-VS-Normal |
3.95160000000727E-05 |
| Other-VS-Normal |
3.035500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.01399999087005E-09 |
| Normal-vs-N1 |
2.88690000016523E-07 |
| N0-vs-N1 |
5.317400E-01 |
|
|
